Fehm T - Search Results

1

Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.

Krawczyk N, Hartkopf A, Banys M, Meier-Stiegen F, Staebler A, Wallwiener M, Röhm C, Hoffmann J, Hahn M, Fehm T. Krawczyk N, et al. Among authors: fehm t. BMC Cancer. 2014 Jun 3;14:394. doi: 10.1186/1471-2407-14-394. BMC Cancer. 2014. PMID: 24894702 Free PMC article.

2

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients.

Fehm T, Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W. Fehm T, et al. Breast Cancer Res Treat. 1997 Mar;43(1):87-95. doi: 10.1023/a:1005700812422. Breast Cancer Res Treat. 1997. PMID: 9065602

3

The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.

Fehm T, Maimonis P, Katalinic A, Jäger WH. Fehm T, et al. Oncology. 1998 Jan-Feb;55(1):33-8. doi: 10.1159/000011832. Oncology. 1998. PMID: 9428373

4

Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients.

Fehm T, Gebauer G, Jäger W. Fehm T, et al. Breast Cancer Res Treat. 2002 Sep;75(2):97-106. doi: 10.1023/a:1019601022456. Breast Cancer Res Treat. 2002. PMID: 12243512

5

Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.

Gebauer G, Fehm T, Merkle E, Jaeger W, Mitze M. Gebauer G, et al. Among authors: fehm t. Anticancer Res. 2003 Sep-Oct;23(5b):4319-24. Anticancer Res. 2003. PMID: 14666645

6

Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.

Fehm T, Jäger W, Krämer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G. Fehm T, et al. Anticancer Res. 2004 May-Jun;24(3b):1987-92. Anticancer Res. 2004. PMID: 15274389 Free article.

7

Influence of tumor biological factors on tumor cell dissemination in primary breast cancer.

Fehm T, Becker S, Pergola-Becker G, Krämer B, Gruber I, Sotlar K, Kurek R, Wallwiener D, Solomayer E. Fehm T, et al. Anticancer Res. 2004 Nov-Dec;24(6):4211-6. Anticancer Res. 2004. PMID: 15736474 Free article.

8

Changes of serum HER2 status during clinical course of metastatic breast cancer patients.

Fehm T, Jäger W, Kraemer S, Sohn C, Solomayer-Meyberg G, Solomayer EF, Kurek R, Wallwiener D, Gebauer G. Fehm T, et al. Anticancer Res. 2004 Nov-Dec;24(6):4205-10. Anticancer Res. 2004. PMID: 15739264 Free article.

9

Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.

Becker S, Becker-Pergola G, Fehm T, Wallwiener D, Solomayer EF. Becker S, et al. Among authors: fehm t. Anticancer Res. 2005 May-Jun;25(3B):2171-5. Anticancer Res. 2005. PMID: 16158960 Free article.

10

Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.

Fehm T, Maul H, Gebauer S, Scharf A, Baier P, Sohn C, Jäger W, Gebauer G. Fehm T, et al. Strahlenther Onkol. 2005 Sep;181(9):580-6. doi: 10.1007/s00066-005-1374-y. Strahlenther Onkol. 2005. PMID: 16170485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters